trial
as of 2026-07-01Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects
NCTId NCT00166322
at a glance
— · Completed
Enrollment 35 (actual)
Sponsored by Ludwig-Maximilians - University of Munich
Primary completion 2007-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
35 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2004-01
Primary completion
2007-12
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Sponsors
Ludwig-Maximilians - University of MunichLead Sponsor
Investigators
2
Oliver Pogarell, MDPrincipal Investigator
Klaus Tatsch, MDPrincipal Investigator
Sites
2 total
Munich, GermanyMunich, Germany
Facts & assertions
4 sourced
Enrollment
35
Phase
NA
Primary Completion Date
2007-12
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
indication
indication
indication
investigator
person
person